396 related articles for article (PubMed ID: 33436017)
21. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
[TBL] [Abstract][Full Text] [Related]
22. Determinants of surgical resection for pancreatic neuroendocrine tumors.
Doi R
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):610-7. PubMed ID: 25773163
[TBL] [Abstract][Full Text] [Related]
23. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
Cai JS; Chen HY; Lu YF; Yu RS
Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
[No Abstract] [Full Text] [Related]
24. Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors.
Toyoda J; Sahara K; Tsilimigras DI; Miyake K; Yabushita Y; Homma Y; Kumamoto T; Matsuyama R; Pawlik TM
World J Surg; 2021 Dec; 45(12):3643-3651. PubMed ID: 34379172
[TBL] [Abstract][Full Text] [Related]
25. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
[TBL] [Abstract][Full Text] [Related]
26. The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis.
Wang S; Zhang J; Liu S; Zhang J
Medicine (Baltimore); 2019 Nov; 98(44):e17773. PubMed ID: 31689842
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
Zhou B; Fang B; Yan S; Wang W
Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
[TBL] [Abstract][Full Text] [Related]
28. The role of oncologic resection and enucleation for small pancreatic neuroendocrine tumors.
Altimari M; Abad J; Chawla A
HPB (Oxford); 2021 Oct; 23(10):1533-1540. PubMed ID: 33832835
[TBL] [Abstract][Full Text] [Related]
29. Palliative Resection of Primary Tumor in Metastatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
Ye H; Xu HL; Shen Q; Zheng Q; Chen P
J Surg Res; 2019 Nov; 243():578-587. PubMed ID: 31031022
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experience.
Oh TG; Chung MJ; Park JY; Bang SM; Park SW; Chung JB; Song SY
Yonsei Med J; 2012 Sep; 53(5):944-51. PubMed ID: 22869477
[TBL] [Abstract][Full Text] [Related]
31. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
32. Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours.
Chopde A; Gupta A; Chaudhari V; Parghane R; Basu S; Ostwal V; Ramaswamy A; Puranik A; Shrikhande SV; Bhandare MS
Langenbecks Arch Surg; 2023 May; 408(1):204. PubMed ID: 37212896
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis.
Mei W; Cao F; Lu J; Qu C; Fang Z; Li J; Li F
Front Endocrinol (Lausanne); 2023; 14():1140873. PubMed ID: 37020595
[TBL] [Abstract][Full Text] [Related]
35. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
37. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors.
Zhou B; Xiang J; Jin M; Zheng X; Li G; Yan S
BMC Cancer; 2021 Mar; 21(1):334. PubMed ID: 33789624
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Tumor Prognosis of Pancreatic Neuroendocrine Tumors Using Image, Surgical and Pathologic Findings.
Chen F; Huang Y; Chen C; Zhang Y; Zhang Y; Wan R; Xu M
Neuro Endocrinol Lett; 2023 Oct; 44(7):453-464. PubMed ID: 37874552
[TBL] [Abstract][Full Text] [Related]
39. Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.
Zhang IY; Zhao J; Fernandez-Del Castillo C; Braun Y; Razmdjou S; Warshaw AL; Lillemoe KD; Ferrone CR
J Gastrointest Surg; 2016 Feb; 20(2):277-83. PubMed ID: 26691146
[TBL] [Abstract][Full Text] [Related]
40. Minimally Invasive Versus Open Pancreatectomy for Right-Sided and Left-Sided G1/G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Multicenter Matched Analysis with an Inverse Probability of Treatment-Weighting Method.
Hwang HK; Song KB; Park M; Kwon W; Jang JY; Heo JS; Choi DW; Kang CM; Park JS; Hong TH; Cho CK; Ahn KS; Lee H; Lee SE; Jeong CY; Roh YH; Kim HJ; Hwang DW; Kim SC; Han HS; Yoon YS;
Ann Surg Oncol; 2021 Nov; 28(12):7742-7758. PubMed ID: 33969463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]